Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $147 |
| Triangulated Fair Value | $139 |
| 12-mo Scenario PWEV | $146 |
| Implied Return | -5% |
| Forward P/E | 21.1x |
| Market Cap | $342B |
| 52-Week Range | $136 – $166 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Defensive Re-Rate' (8% weight) — targets $231, +58% vs spot. It needs the multiple to hold or expand.
The dashboard below is the whole argument on one page: spot ($147) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Private-Label / Brand Erosion' (20%) — targets $68, -54% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
P/E Multiple explains 65% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.36 vs analyst floor +0.14 → delta +0.22 (n=30 mgmt / 16 Q&A; 16th pctile across the S&P book, z -1.1).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.36 | +0.14 | +0.22 |
| 2026Q1 | +0.37 | +0.18 | +0.19 |
| 2025Q4 | +0.41 | +0.17 | +0.24 |
| 2025Q3 | +0.30 | -0.00 | +0.30 |
News (last 365d, 1000 articles): avg ticker sentiment +0.16 (bullish 16% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Private-Label / Brand Erosion' downside ($68) to a 'Bull — Defensive Re-Rate' bull case ($231); the probability-weighted blend (PWEV $146) is -0% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 20% | $68 | -54% |
| Consumer / Input Recession | 18% | $120 | -18% |
| Base — Pricing-Led Organic Growth | 34% | $156 | +6% |
| Growth — Premium Innovation + EM | 20% | $197 | +34% |
| Bull — Defensive Re-Rate | 8% | $231 | +58% |
| Probability-Weighted (PWEV) | — | $146 | -0% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Private-Label / Brand Erosion (20%, $68). Structural impairment — private-label / brand erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 67.72; probability: 0.2.
- Consumer / Input Recession (18%, $120). Cyclical downturn — branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) weakens for 1–2 years before normalising. Drivers — implied_target: 120.32; probability: 0.18.
- Base — Pricing-Led Organic Growth (34%, $156). Mid-cycle — normalised branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail); disciplined capital allocation; steady returns. Drivers — implied_target: 155.69; probability: 0.34.
- Growth — Premium Innovation + EM (20%, $197). Upside — premium innovation + emerging markets lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 196.58; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $231). Upside tail — sustained tight conditions or a structural re-rate on premium innovation + emerging markets. Drivers — implied_target: 231.21; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $131 | -11% |
| Peer P/E re-rate | multiple | $176 | +20% |
| Peer EV/Revenue re-rate | multiple | $88 | -40% |
| Scenario PWEV | multiple | $146 | -0% |
| DCF (5-year + terminal) | cash flow + terminal × | $126 | -14% |
| Triangulated (weighted) | — | $139 | -5% |
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $131 and 38% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (65% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 7.5%, 18x terminal FCF multiple → $126. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 25.395x) implies $176. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is tight (the methods corroborate one another).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Household & Personal Care | $86.7B | 100% | 4% | 23% | 21x | 3% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) |
| net_debt_or_cash_b | -24.72 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.0278 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | private-label / brand erosion |
| upside | premium innovation + emerging markets |
Industry Context — Consumer Staples — Household
This name sits in the Consumer Staples — Household as a household_personal. branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: PG (household_personal) · CL (household_personal) · KVUE (household_personal) · KMB (household_personal) · EL (household_personal) · CHD (household_personal) · CLX (household_personal)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 38% | 38% | |
| Mid-Cycle — Pricing-Led Organic Growth | 34% | 34% | |
| Upside — Premium Innovation / EM | 28% | 28% |
On the cluster's key downside — Structural — Private-Label / Brand Erosion () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_household cycle is the shared macro driver. Driver — branded HPC pricing power + organic volume + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $90B | $21B | $3B | $3B | $16B | $15B |
| FY+2 | $94B | $22B | $3B | $3B | $17B | $15B |
| FY+3 | $98B | $24B | $3B | $3B | $19B | $15B |
| FY+4 | $100B | $25B | $3B | $3B | $19B | $14B |
| FY+5 | $103B | $25B | $3B | $3B | $20B | $14B |
| Terminal | — | — | — | — | $20B × 18x | $246B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.5% · Σ PV(FCF) $73B + PV(terminal) $246B = EV $319B; + net cash → equity $295B ÷ diluted shares 2.33B = $126/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $141/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 24% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| KVUE | 2.886x | 16.47x | 4% | 22% |
| EL | 2.404x | 26.04x | 4% | 15% |
| KO | 7.65x | 24.75x | 5% | 35% |
| COST | 1.383x | 41.84x | 5% | 4% |
| Median | 2.645x | 25.395x | — | — |
Peer-median fwd P/E → $176; EV/Rev → $88.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $126 | 41% | $52 |
| Scenario PWEV | $146 | 29% | $43 |
| Monte Carlo median | $131 | 18% | $23 |
| Peer P/E | $176 | 12% | $21 |
| Triangulated | — | 100% | $139 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 12.6x | 15.3x | 18.0x | 20.7x | 23.4x |
|---|---|---|---|---|---|
| 6% | $104 | $121 | $139 | $156 | $173 |
| 6% | $99 | $116 | $132 | $149 | $166 |
| 8% | $95 | $111 | $126 | $142 | $158 |
| 8% | $91 | $106 | $121 | $136 | $151 |
| 10% | $87 | $101 | $116 | $130 | $144 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $96 | $103 | $111 | $118 | $125 |
| -1.5pp | $102 | $110 | $118 | $126 | $134 |
| +0.0pp | $110 | $118 | $126 | $135 | $143 |
| +1.5pp | $117 | $126 | $135 | $144 | $153 |
| +3.0pp | $125 | $135 | $144 | $154 | $163 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $111 | $144 | $34 |
| Op margin ±3pp | $110 | $143 | $34 |
| Terminal × ±15% | $111 | $142 | $32 |
| WACC ±1pp | $121 | $132 | $12 |
| FCF conversion ±10% | $126 | $126 | $0 |
Company lever — SoP/share vs Household & Personal Care multiple (AI re-rating) (base 21x)
| Multiple | 14.7x | 17.8x | 21.0x | 24.1x | 27.3x |
|---|---|---|---|---|---|
| SoP/share | $537 | $652 | $771 | $887 | $1,006 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 18×, FY+5 revenue $103B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
The valuation is multiple-dependent (65% of variance); a de-rating toward the DCF anchor ($126) implies -14%.
Fact / Inference / Speculation
- FACT: Spot $147; 52-week range $136–$166; engine rating HOLD; base-case target $146 (-0%).
- INFERENCE: Triangulated FV $139 (-5%). P/E Multiple explains 65% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
- SPECULATION: At current prices the embedded bet is that the multiple holds or expands — P/E Multiple carries 65% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $139 (-5% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple (65% of variance) — fundamentally a multiple/regime call. SBC runs —M TTM (disclosed in the appendix).